Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Hepatocellular Carcinoma - Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 07 Dec 17

The "Hepatocellular Carcinoma - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Hepatocellular Carcinoma - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Hepatocellular Carcinoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hepatocellular Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hepatocellular Carcinoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 12, 79, 51, 3, 72, 10 and 2 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 1, 11, 7, 1, 26 and 2 molecules, respectively.

Hepatocellular Carcinoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Hepatocellular Carcinoma - Overview
  3. Hepatocellular Carcinoma - Therapeutics Development
  4. Hepatocellular Carcinoma - Therapeutics Assessment
  5. Hepatocellular Carcinoma - Companies Involved in Therapeutics Development
  6. Hepatocellular Carcinoma - Drug Profiles
  7. Hepatocellular Carcinoma - Dormant Projects
  8. Hepatocellular Carcinoma - Discontinued Products
  9. Hepatocellular Carcinoma - Product Development Milestones
  10. Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 07/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.